Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 17Terminated 4Unknown 2Active not recruiting 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 102Other hematologic neoplasm 34Myeloid 25Plasma cell 18Classical hematology 8Dermatologic 7Breast 7Sarcoma 5CNS 5Gynecologic 4Genitourinary 4Thoracic 3Gastrointestinal 3Other solid neoplasm 1Other neoplasm 1Head & Neck 1Endocrine 1

Conditions

Squamous Cell Carcinoma of Head and Neck 370Head and Neck Neoplasms 356Nasopharyngeal Carcinoma 140Thyroid Neoplasms 124Carcinoma, Non-Small-Cell Lung 93Mouth Neoplasms 84Melanoma 76Breast Neoplasms 75Oropharyngeal Neoplasms 72Colorectal Neoplasms 68Uterine Cervical Neoplasms 66Lung Neoplasms 66Neoplasms 63Ovarian Neoplasms 61Neoplasm Metastasis 52Prostatic Neoplasms 51Stomach Neoplasms 49Pancreatic Neoplasms 47Carcinoma, Squamous Cell 45Triple Negative Breast Neoplasms 43Laryngeal Neoplasms 42Esophageal Neoplasms 42Endometrial Neoplasms 42Thyroid Nodule 37Carcinoma, Renal Cell 37Urinary Bladder Neoplasms 36Sarcoma 34Recurrence 31Carcinoma 30Nasopharyngeal Neoplasms 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hodgkin Disease × Head & Neck × Clear all
NCT06150664 2026-04-20

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Compass Therapeutics

Phase 1 Recruiting
85 enrolled
BreastDermatologicHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Hodgkin Disease, Melanoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡